Annual progress reports
All eligible countries are invited to submit proposals for Gavi support.
Annual progress report Myanmar 2012
Annual progress report Myanmar 2011
Annual progress report Myanmar 2010
Annual progress report Myanmar 2009
Annual progress report Myanmar 2008
Annual progress report Myanmar 2007
Annual progress report Myanmar 2006
Annual progress report Myanmar 2004
Annual progress report Myanmar 2005
Annual progress report Myanmar 2003
Annual progress report Myanmar 2002
Annual progress report Myanmar 2001
Annual progress report Myanmar 2014
Annual progress report Myanmar 2013
Proposal for NVS - HPV vaccine (2020-2021): Myanmar
Proposal for NVS - MR follow-up and rota support 2019 - Myanmar
Proposal for CCEOP support 2017: Myanmar
Proposal for NVS - JE support: Myanmar
Proposal for HSS support 2016: Myanmar
Proposal for Pneumo Support 2015: Myanmar
Proposal for NVS - IPV support: Myanmar
Proposal for MR support: Myanmar
Proposal for NVS - Penta support: Myanmar
Proposal for NVS - MSD support: Myanmar
Proposal for ISS support: Myanmar
Proposal for HSS support: Myanmar
Proposal for ISS, INS support: Myanmar
Comprehensive multi-year plans/Financial sustainability plans
The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives.
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Co-financing information sheet Myanmar
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
Decision Letter NVS Myanmar 2019
Decision Letter NVS Myanmar 2016
Decision Letter HSS Myanmar 2018
Decision Letter NVS Myanmar 2015 (3)
Decision Letter Devices Myanmar 2017 (2)
Decision Letter NVS Myanmar 2015 (2)
Decision Letter NVS Myanmar 2015
Decision Letter NVS Myanmar 2017 (3)
Decision Letter HSS Myanmar 2014
Decision Letter NVS Myanmar 2017 (4)
Decision Letter NVS Myanmar 2014(2)
Decision Letter NVS Myanmar 2017 (5)
Decision Letter NVS Myanmar 2014(3)
Decision Letter CCEOP Myanmar 2017
Decision Letter NVS Myanmar 2014
Decision Letter NVS Myanmar 2017 (2)
Decision letter NVS and HSS Myanmar 2013
Decision Letter NVS Myanmar 2017
Decision Letter Devices Myanmar 2017
Decision Letter Devices Myanmar 2016 (2)
Decision Letter NVS Myanmar 2016 (5)
Decision Letter Devices Myanmar 2016
Decision Letter NVS Myanmar 2016 (2)
Decision Letter Myanmar MR 2019
Decision Letter NVS Myanmar 2016 (3)
Decision Letter ISD Myanmar 2019
Decision Letter NVS Myanmar 2016 (4)
COVAX Technical Assistance Plans
In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.
COVAX Technical Assistance Plan Myanmar 2021
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.
The joint appraisal report
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.